vimarsana.com

Disc Medicine Opco (NASDAQ:IRON – Get Rating) had its price target boosted by equities researchers at Stifel Nicolaus from $50.00 to $65.00 in a note issued to investors on Friday, The Fly reports. Stifel Nicolaus’ price target suggests a potential upside of 23.88% from the stock’s current price. Several other research analysts have also commented […]

Related Keywords

Raymond James ,Stifel Nicolau ,Stifel Nicolaus ,Disc Medicine Opco Inc ,Capital Management ,Morgan Stanley ,Atlas Venture Life Science Advisors ,Foresite Capital Management ,Disc Medicine Opco Company Profile ,Trustees Of Columbia University ,Disc Medicine Opco ,Get Rating ,Medicine Opco ,Venture Life Science Advisors ,Columbia University ,New York ,Medicine Opco Inc ,Disc Medicine Opco Daily ,Nasdaq Iron ,Iron ,Medical ,Boost Price Target ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.